Clinical trial
Double Blind Randomized Trial of Wound Infiltration With Ropivacaine After Breast Cancer Surgery
NCT01404377 is registered in ClinicalTrials.gov with Tenon Hospital, Paris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double Blind Randomized Trial of Wound Infiltration With Ropivacaine After Breast Cancer Surgery
- Lead sponsor
- Tenon Hospital, Paris
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2006
- Completion date
- January 31, 2009
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer